Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
Retinoblastoma is the most common cancer in children. The process of treating retinoblastoma has been amazing...
Read Full NewsForget salary. The cities winning the physician satisfaction race are playing a completely different game.
The prevalence of type 2 diabetes is rising among US youth, and if we don’t address the real causes, we really will see a potentially unstoppable surge.
Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.
Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.
The Red Cross on Saturday paid tribute to three volunteers who are believed to have died after contracting Ebola while handling bodies.
Americans coming back from the Democratic Republic of the Congo, Uganda or South Sudan now have a second entry point for returning to the United States, with the CDC on...
1.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
2.
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer
3.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
4.
Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer
5.
Traveling to Die: The Latest Form of Medical Tourism
1.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
2.
Unlocking the Immune Arsenal: A Revolution in Cancer Treatment
3.
Polycythemia Vera: A Historical Perspective and Contemporary Management
4.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
5.
Colon cancer: Risk factors, warning signs and treatment options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge